Consensus statement on the management of urticaria

This consensus statement was developed by Special Interest Group - Urticaria (IADVL). Urticaria, a heterogeneous group of diseases, often cannot be recognized by its morphology. Due to non-specific and non-affordable diagnosis, management of urticaria, especially chronic urticaria, is very challengi...

Full description

Bibliographic Details
Main Authors: Kiran V Godse, Vijay Zawar, D S Krupashankar, Mukesh Girdhar, Sanjiv Kandhari, Sandipan Dhar, Sanjay Ghosh, Murlidhar Rajagopalan, Torsten Zuberbier
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2011-01-01
Series:Indian Journal of Dermatology
Subjects:
Online Access:http://www.e-ijd.org/article.asp?issn=0019-5154;year=2011;volume=56;issue=5;spage=485;epage=489;aulast=Godse
id doaj-cdac775a3f2f4a17a49b9bc5402754cf
record_format Article
spelling doaj-cdac775a3f2f4a17a49b9bc5402754cf2020-11-24T23:52:35ZengWolters Kluwer Medknow PublicationsIndian Journal of Dermatology0019-51541998-36112011-01-0156548548910.4103/0019-5154.87119Consensus statement on the management of urticariaKiran V GodseVijay ZawarD S KrupashankarMukesh GirdharSanjiv KandhariSandipan DharSanjay GhoshMurlidhar RajagopalanTorsten ZuberbierThis consensus statement was developed by Special Interest Group - Urticaria (IADVL). Urticaria, a heterogeneous group of diseases, often cannot be recognized by its morphology. Due to non-specific and non-affordable diagnosis, management of urticaria, especially chronic urticaria, is very challenging. This guideline includes definition, causes, classification and management of urticaria. Urticaria has a profound impact on the quality of life and causes immense distress to patients, necessitating effective treatment. One approach to manage urticaria is identification and elimination of the underlying cause(s) and/or eliciting trigger(s), while the second one is treatment aimed at providing symptomatic relief. This guideline recommends use of second-generation non-sedating H1 antihistamines as the first-line treatment. The dose can be increased up to four times to meet the expected results. In case patients still do not respond, appropriate treatment options can be selected depending on the cost.http://www.e-ijd.org/article.asp?issn=0019-5154;year=2011;volume=56;issue=5;spage=485;epage=489;aulast=GodseChronic urticariaconsensus statementdefinitiontreatmenturticaria
collection DOAJ
language English
format Article
sources DOAJ
author Kiran V Godse
Vijay Zawar
D S Krupashankar
Mukesh Girdhar
Sanjiv Kandhari
Sandipan Dhar
Sanjay Ghosh
Murlidhar Rajagopalan
Torsten Zuberbier
spellingShingle Kiran V Godse
Vijay Zawar
D S Krupashankar
Mukesh Girdhar
Sanjiv Kandhari
Sandipan Dhar
Sanjay Ghosh
Murlidhar Rajagopalan
Torsten Zuberbier
Consensus statement on the management of urticaria
Indian Journal of Dermatology
Chronic urticaria
consensus statement
definition
treatment
urticaria
author_facet Kiran V Godse
Vijay Zawar
D S Krupashankar
Mukesh Girdhar
Sanjiv Kandhari
Sandipan Dhar
Sanjay Ghosh
Murlidhar Rajagopalan
Torsten Zuberbier
author_sort Kiran V Godse
title Consensus statement on the management of urticaria
title_short Consensus statement on the management of urticaria
title_full Consensus statement on the management of urticaria
title_fullStr Consensus statement on the management of urticaria
title_full_unstemmed Consensus statement on the management of urticaria
title_sort consensus statement on the management of urticaria
publisher Wolters Kluwer Medknow Publications
series Indian Journal of Dermatology
issn 0019-5154
1998-3611
publishDate 2011-01-01
description This consensus statement was developed by Special Interest Group - Urticaria (IADVL). Urticaria, a heterogeneous group of diseases, often cannot be recognized by its morphology. Due to non-specific and non-affordable diagnosis, management of urticaria, especially chronic urticaria, is very challenging. This guideline includes definition, causes, classification and management of urticaria. Urticaria has a profound impact on the quality of life and causes immense distress to patients, necessitating effective treatment. One approach to manage urticaria is identification and elimination of the underlying cause(s) and/or eliciting trigger(s), while the second one is treatment aimed at providing symptomatic relief. This guideline recommends use of second-generation non-sedating H1 antihistamines as the first-line treatment. The dose can be increased up to four times to meet the expected results. In case patients still do not respond, appropriate treatment options can be selected depending on the cost.
topic Chronic urticaria
consensus statement
definition
treatment
urticaria
url http://www.e-ijd.org/article.asp?issn=0019-5154;year=2011;volume=56;issue=5;spage=485;epage=489;aulast=Godse
work_keys_str_mv AT kiranvgodse consensusstatementonthemanagementofurticaria
AT vijayzawar consensusstatementonthemanagementofurticaria
AT dskrupashankar consensusstatementonthemanagementofurticaria
AT mukeshgirdhar consensusstatementonthemanagementofurticaria
AT sanjivkandhari consensusstatementonthemanagementofurticaria
AT sandipandhar consensusstatementonthemanagementofurticaria
AT sanjayghosh consensusstatementonthemanagementofurticaria
AT murlidharrajagopalan consensusstatementonthemanagementofurticaria
AT torstenzuberbier consensusstatementonthemanagementofurticaria
_version_ 1725473071381348352